Review Article
Brachytherapy for Prostate Cancer: A Systematic Review
Table 1
LDR brachytherapy: clinical results for patients with low-risk prostate cancer.
| Author | Number of patients | PSA relapse definition | Median followup | Years after diagnosis | % of biochimical free reccurence |
| Ellis et al. [21] | 239 | ASTRO | 47 MONTHS | 7 | 96 | Zelefsky et al. [22] | 319 | ASTRO | 63 MONTHS | 5 | 96 | Zelefsky et al. [23] | 1444 | ASTRO | 63 MONTHS | 8 | 82 | Block et al. [24] | 118 | ASTRO | 49 MONTHS | 5 | 94.7 | Khaksar et al. [25] | 146 | ASTRO | 45 MONTHS | 5 | 96 | Guedea et al. [26] | 241 | ASTRO | 30 MONTHS | 3 | 93 | Stock et al. [14] | 589 | ASTRO | 4.2 YEARS | 10 | 94 | Prada et al. [27] | 275 | ASTRO | 31 MONTHS | 5 | 96 | Potters et al. [28] | 481 | ASTRO-Kattan | 82 MONTHS | 12 | 89 | Sharkey et al. [29] | 1707 | ASTRO | — | 12 | 89 | Joseph et al. [30] | 667 | ASTRO | 31 MONTHS | 8 | 84.3 | Critz and Levinson [31] | 1469 | 0.2 ng/mL | 6 YEARS | 10 | 93 | Bladou et al. [32] | 177 | NOT DEFINED | 29 MONTHS | 3 | 98 | Battermann et al. [33] | 114 | ASTRO | 48 MONTHS | 5 | 89 | D’Amico et al. [34] | 196 | ASTRO | 3.9 YEARS | 5 | 95 | Sylvester et al. [35] | 73 | 2 PSA rises | 63 MONTHS | 10 | 89 | Kwok et al. [36] | 41 | ASTRO | 7 YEARS | 5 | 85 | Grimm et al. [37] | 125 | 2 PSA RISES | 81 MONTHS | 10 | 87 | Wallner et al. [38] | 126 | 0.5 ng/mL | 2.9 YEARS | 3 | 89–91 | Martin et al. [39] | 273 | Houston | 5 YEARS | 12 | 90 | Merrick et al. [40] | 120 | ASTRO | 31 MONTHS | 5 | 97 |
|
|